PF

Pascal Furet

NA Novartis Ag: 86 patents #1 of 5,128Top 1%
IR Irm: 7 patents #35 of 277Top 15%
CI Ciba-Geigy: 4 patents #661 of 2,867Top 25%
SC Schering: 4 patents #698 of 2,442Top 30%
EA Elanco Tiergesundheit Ag: 2 patents #3 of 43Top 7%
CL Cancer Research Campaign Technology Limited: 1 patents #59 of 134Top 45%
NA Novatis Ag: 1 patents #2 of 21Top 10%
📍 Thann, FR: #1 of 38 inventorsTop 3%
Overall (All Time): #15,452 of 4,157,543Top 1%
97
Patents All Time

Issued Patents All Time

Showing 76–97 of 97 patents

Patent #TitleCo-InventorsDate
7514447 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Valentina Molteni, Xiaolin Li, Donatella Chianelli, Jon Loren, Juliet Nabakka +6 more 2009-04-07
7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors Guido Bold, Paul W. Manley 2009-01-27
7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives Hans-Georg Capraro, Carlos Garcia-Echeverria, Paul W. Manley 2008-02-05
7189729 Methods and compositions as protein kinase inhibitors Greg Chopiuk, Nathanael S. Gray, Patricia Imbach, Yi Liu, Joseph Schoepfer +1 more 2007-03-13
7169791 Inhibitors of tyrosine kinases Werner Breitenstein, Sandra Jacob, Paul W. Manley 2007-01-30
7122547 Anthranilic acid amides and the use thereof as medicaments Andreas Huth, Dieter Seidelmann, Karl-Heinz Thierauch, Guido Bold, Paul W. Manley +8 more 2006-10-17
7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors Guido Bold, Paul W. Manley 2006-08-15
7091346 Purine derivatives and processes for their preparation Jurg Zimmermann, Hans-Georg Capraro, Patricia Imbach 2006-08-15
7083983 Inhibitors of the interaction between P53 and MDM2 David Philip Lane, Volker Böttger, Angelika Bottger, Steven Michael Picksley, Heinz-Kurt Hochkeppel +2 more 2006-08-01
7067543 Anthranilic acid amides and pharmaceutical use thereof Guido Bold, Paul W. Manley 2006-06-27
7002022 N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF Karl-Heinz Altmann, Guido Bold, Paul W. Manley, Jeanette Marjorie Wood, Stefano Ferrari +8 more 2006-02-21
6933290 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives Vito Guagnano, Patricia Imbach, Marc Lang 2005-08-23
6878720 VEGF receptor tyrosine kinase inhibitors Karl-Heinz Altmann, Guido Bold, Paul W. Manley, Jeanette Marjorie Wood, Stefano Ferrari +8 more 2005-04-12
6767906 2-amino-6-anilino-purines and their use as medicaments Patricia Imbach, Hans-Georg Capraro, Jurg Zimmermann, Giorgio Caravatti, Wolfgang Brill 2004-07-27
6448277 VEGF receptor tyrosine kinase inhibitors Karl-Heinz Altmann, Guido Bold, Paul W. Manley, Jeanette Marjorie Wood, Stefano Ferrari +8 more 2002-09-10
6096749 Pyrrolopyrimidine derivatives having pharmacological activity Peter Traxler, Wolfgang Brill 2000-08-01
5981533 Pyrazole derivatives and processes for the preparation thereof Peter Traxler, Guido Bold, Jorg Frei, Marc Lang 1999-11-09
5686457 Pyrrolopyrimidine derivatives having pharmacological activity Peter Traxler, Wolfgang Brill 1997-11-11
5683997 Substituted benzazepinones Peter Buhlmayer 1997-11-04
5610153 Benzazepinone derivatives Peter Buhlmayer 1997-03-11
5424441 N-aralkyl-and N-heteroaralkyl-aminoalkanephosphinic acids Stuart J. Mickel, Wolfgang Frostl 1995-06-13
5332729 N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids Stuart J. Mickel, Wolfgang Frostl 1994-07-26